AI R&D Drug Startup XtalPi raises $318M
XtalPi, an Artificial Intelligence (AI) drug discovery and development technology company, announced today an oversubscribed Series C funding round of $318.8 million
China
Healthcare is primary focus for European AI companies
MMC Ventures, which invests in AI companies, has published its State of AI 2019 report, revealing rapid recent progress in AI adoption in healthcare.